Velphoro nod for Vifor in Europe
This article was originally published in Scrip
Executive Summary
Vifor Pharma (part of Swiss firm Galenica) has obtained EU marketing authorization for Velphoro (sucroferric oxyhydroxide) for the control of serum phosphorus levels in adult patients with chronic kidney disease (CKD) on hemodialysis or peritoneal dialysis. This follows a positive opinion in June from the EMA's CHMP.